Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Mahmoud Hadipour Dehshal"'
Publikováno v:
International Journal of Hematology-Oncology and Stem Cell Research, Vol 17, Iss 1 (2023)
Editorial
Externí odkaz:
https://doaj.org/article/b494b138a0d34410bdfbf943a8c67923
Publikováno v:
Global Journal of Transfusion Medicine, Vol 8, Iss 1, Pp 107-107 (2023)
Externí odkaz:
https://doaj.org/article/1635816d01304ceb931739e92e19d2e9
Autor:
Ali Akbar Pourfathollah, Gharib Karimi, Mehdi Tabrizi Namini, Sakineh Yousefi Darestani, Mahmoud Hadipour Dehshal
Publikováno v:
Global Journal of Transfusion Medicine, Vol 4, Iss 1, Pp 65-68 (2019)
Introduction: Patient blood management (PBM) is of prime importance today for the preservation and conservation of health resources and for patient safety. To fulfill the goal of appropriate use of blood and blood components, all the shareholders inv
Externí odkaz:
https://doaj.org/article/e5480bfbbf99461c9a616a4e2e9f6753
Autor:
Mahmoud Hadipour Dehshal
Publikováno v:
Global Journal of Transfusion Medicine, Vol 5, Iss 2, Pp 232-232 (2020)
Externí odkaz:
https://doaj.org/article/73f3604e9f514d64a3107d1d4f4357ca
Autor:
Mahmoud Hadipour Dehshal
Publikováno v:
Thalassemia Reports, Vol 8, Iss 1 (2018)
Access to the essential medicines is an important challenge in the developing countries. To have access to the quality and affordable medicines, the pharmaceutical decision makers try different strategies. The production of generic and copy medicines
Externí odkaz:
https://doaj.org/article/db6296c229da409d80ebaf3e76345e2b
Autor:
Mahmoud Hadipour Dehshal
Publikováno v:
Thalassemia Reports, Vol 5, Iss 1 (2015)
Not required
Externí odkaz:
https://doaj.org/article/ec4ce9fb351a470ab64440c6c93ce50c
Autor:
Mahmoud Hadipour Dehshal
Publikováno v:
Thalassemia Reports, Vol 4, Iss 3 (2014)
Adherence to treatment is a great concern for patients who need long-life treatment. Thalassaemia is an inherited disease for whose treatment team-working is of a considerable importance. To logically face the problem of poor compliance patients, all
Externí odkaz:
https://doaj.org/article/9467a21f181e428199b10518f7257556
Autor:
Sakineh Yousefi Darestani, Mehdi Tabrizi Namini, Mahmoud Hadipour Dehshal, Razieh Hantoushzadeh
Publikováno v:
Hemoglobin. 43:166-173
Iran, as a country located in the Thalassemia Belt, has made great progress in thalassemia prevention and treatment. The thalassemia prevention program was implemented in 1995 and the country-wide thalassemia treatment network, consisting of 64 medic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7406e904ad89621ea4979e386f862f06
https://doi.org/10.1080/03630269.2019.1628774
https://doi.org/10.1080/03630269.2019.1628774
Publikováno v:
International Journal of Hematology-Oncology & Stem Cell Research; Jan2023, Vol. 17 Issue 1, p1-3, 3p
Autor:
Michael Angastiniotis, Sachiko Hosoya, Mehdi Tabrizi Namini, Fatemeh Hashemi Bahremani, Androulla Eleftheriou, Mahmoud Hadipour Dehshal
Publikováno v:
Thalassemia Reports; Volume 11; Issue 1; Pages: 9514
Thalassemia is one of the important challenges of the health system in Iran. Recently the medicinal drug of luspatercept and gene therapy have opened new horizons for thalassemia treatment. The present article aims to evaluate the attitude of thalass
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f33d2f42450f86c85b172ddc2bd640f9
https://doi.org/10.4081/thal.2021.9514
https://doi.org/10.4081/thal.2021.9514